NGF and osteoarthritis: In contrast to anti-NGF inhibitors, they target the mechanistic pathophysiology of osteoarthritis by regulating catabolic and anabolic processes in the cartilage and bone or inflammatory responses in the synovium, but do not address the modulation of acute and chronic pain by effecting nociceptor sensitization.